- Home
- PROK vs FTK Comparison
PROK vs FTK Comparison
Compare PROK & FTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- FTK
- Stock Information
- Founded
- PROK 2015
- FTK 1985
- Country
- PROK United States
- FTK United States
- Employees
- PROK 163
- FTK N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- FTK Major Chemicals
- Sector
- PROK Health Care
- FTK Industrials
- Exchange
- PROK Nasdaq
- FTK Nasdaq
- Market Cap
- PROK 212.4M
- FTK 219.3M
- IPO Year
- PROK N/A
- FTK N/A
- Fundamental
- Price
- PROK $1.66
- FTK $8.84
- Analyst Decision
- PROK Buy
- FTK Strong Buy
- Analyst Count
- PROK 5
- FTK 2
- Target Price
- PROK $4.50
- FTK $7.50
- AVG Volume (30 Days)
- PROK 566.3K
- FTK 310.1K
- Earning Date
- PROK 11-12-2024
- FTK 03-11-2025
- Dividend Yield
- PROK N/A
- FTK N/A
- EPS Growth
- PROK N/A
- FTK N/A
- EPS
- PROK N/A
- FTK 0.27
- Revenue
- PROK N/A
- FTK $178,455,000.00
- Revenue This Year
- PROK N/A
- FTK N/A
- Revenue Next Year
- PROK N/A
- FTK $13.93
- P/E Ratio
- PROK N/A
- FTK $32.57
- Revenue Growth
- PROK N/A
- FTK N/A
- 52 Week Low
- PROK $1.18
- FTK $2.64
- 52 Week High
- PROK $4.44
- FTK $10.35
- Technical
- Relative Strength Index (RSI)
- PROK 46.29
- FTK 54.08
- Support Level
- PROK $1.50
- FTK $8.30
- Resistance Level
- PROK $1.90
- FTK $9.21
- Average True Range (ATR)
- PROK 0.15
- FTK 0.52
- MACD
- PROK -0.01
- FTK -0.08
- Stochastic Oscillator
- PROK 45.45
- FTK 26.34
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven company focused on reducing the environmental impact of energy operations. Its Chemistry Technologies segment develops green specialty chemicals to enhance the profitability of hydrocarbon producers, catering to major players in the oil and gas industry. These chemicals improve operational efficiency and sustainability throughout the well life cycle. The Data Analytics segment provides real-time analytics for hydrocarbon streams, enabling users to optimize processes and increase profitability by reducing waste and reprocessing. Flotek's revenue primarily comes from its Chemistry segment, reflecting its commitment to providing solutions for environmental improvement in the energy sector.